Can an MMR shot be given to people taking Cosentyx (secukinumab)?
Cosentyx (secukinumab) is a biologic that blocks IL-17A. Because of its immune-modulating effect, the main risk in general with vaccinations is whether the vaccine is “live.” Live vaccines are the ones most likely to cause problems when immune responses are weakened.
MMR is a live, attenuated vaccine, so it is typically avoided in people who are significantly immunosuppressed or who use biologic immune therapies. [1]
What are the specific risks if someone on Cosentyx receives MMR anyway?
If MMR is given to a person on an immunosuppressive biologic, the main potential concerns are:
- The vaccine virus could replicate more than expected in a weakened immune system, which can raise the risk of vaccine-related infection rather than just a normal immune response. [1]
- The immune response to the vaccine may be impaired, so protection may be weaker or delayed, even if no serious adverse event occurs. [1]
These are the core risks clinicians try to prevent by avoiding live vaccines during IL-17–blocking therapy.
How do timing and dosing affect the risk?
For patients who are planning immunosuppressive therapy or restarting it after a pause, timing can matter because the level of immune effect changes over time. In practice, clinicians often:
- Avoid live vaccines during active therapy.
- Consider vaccinating with live vaccines before starting the biologic, or after an appropriate interval when the immune effect is lower.
The exact “safe window” depends on the individual therapy plan and local guidance. Your prescriber can determine an appropriate schedule based on when Cosentyx is started and how often doses are given. [1]
What should patients do instead of MMR while on Cosentyx?
Instead of MMR during Cosentyx treatment, clinicians usually use non-live alternatives when possible, and rely on:
- Checking immune status/history (prior MMR doses or confirmed immunity).
- Catch-up vaccination planning before starting biologics when feasible.
- Using inactivated vaccines for other recommended immunizations during therapy (MMR is live, so it does not fall into that category). [1]
If MMR protection is urgently needed (for example, exposure or travel), the risk-benefit decision is individualized with the treating specialist.
What side effects are most concerning after vaccination on Cosentyx?
If MMR is administered to someone taking Cosentyx despite precautions, the key “red flag” concern is illness that looks like measles, mumps, or rubella occurring shortly after vaccination. Any concerning symptoms should be assessed promptly by a clinician, especially in the setting of immune-modifying medication.
Are there situations where MMR might still be considered?
Sometimes clinicians may still consider vaccination if the patient is not considered sufficiently immunosuppressed, or if the vaccination is required and no safe alternative exists. That said, standard practice with live vaccines like MMR is to avoid them during biologic immune therapy unless specialist guidance says otherwise. [1]
---
Sources
[1] DrugPatentWatch.com – Cosentyx (secukinumab) related safety/regulatory context: https://www.drugpatentwatch.com/